결핵 진단 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 검사 유형별, 최종 용도별, 지역별, 경쟁별(2020-2030년)
Tuberculosis Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type, By End-use, by Region, and Competition, 2020-2030F
상품코드:1881514
리서치사:TechSci Research
발행일:2025년 11월
페이지 정보:영문 182 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 결핵 진단 시장은 2024년에 25억 2,000만 달러로 평가되었으며, 2030년까지 CAGR 6.37%로 성장하여 36억 5,000만 달러에 달할 것으로 예측됩니다.
세계 결핵 진단 시장은 결핵의 원인균인 결핵균(*Mycobacterium tuberculosis*)을 확인하기 위한 검사법 및 도구를 개발 및 도입하고 있습니다. 시장 확대는 전 세계 질병 부담의 심각성과 신속하고 정확한 검출의 필요성에 의해 촉진되고 있습니다. 특히 분자 검사법의 기술적 진보와 더불어 결핵 대책에 대한 정부 및 단체의 지원 증가는 더욱 성장을 촉진하고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
25억 2,000만 달러
시장 규모 : 2030년
36억 5,000만 달러
CAGR : 2025-2030년
6.37%
가장 빠르게 성장하는 부문
진단 검사실 방법
최대 시장
북미
주요 시장 촉진요인
진단 기술의 발전은 검사 솔루션의 속도, 정확성 및 접근성을 향상시킴으로써 세계 결핵 진단 시장을 크게 견인하고 있습니다. 분자진단, 인공지능을 활용한 영상 진단, 차세대 염기서열 분석 등의 혁신 기술은 진단의 지형을 바꾸고, 질병을 조기에 발견하고 보다 효과적으로 관리할 수 있도록 돕고 있습니다.
주요 시장 과제
자원이 한정된 지역에서 저렴한 가격으로 이용할 수 있는 첨단 진단 기술을 확보하는 것은 세계 결핵 진단 시장 확대에 큰 장벽이 되고 있습니다. 첨단 분자진단 플랫폼에 필요한 고가의 장비 투자에 더해 시약 및 소모품의 지속적인 비용 지출은 결핵에 대한 부담이 큰 저소득 국가의 공중보건 시스템에 큰 재정적 장벽이 되고 있습니다.
주요 시장 동향
자동화 진단 플랫폼의 등장은 검사 처리 능력과 운영 효율성을 향상시킴으로써 전 세계 결핵 진단 시장을 크게 견인하고 있습니다. 이러한 시스템은 검사실의 워크플로우를 간소화하고, 수작업을 최소화하며, 검체 처리 속도를 높여 결과 보고까지 걸리는 시간을 단축합니다.
The Global Tuberculosis Diagnostics Market, valued at USD 2.52 Billion in 2024, is projected to experience a CAGR of 6.37% to reach USD 3.65 Billion by 2030. The global tuberculosis diagnostics market develops and deploys tests and tools for identifying *Mycobacterium tuberculosis*, the causative agent of tuberculosis. Market expansion is driven by the significant global disease burden and the imperative for swift, precise detection. Technological advancements, particularly in molecular assays, alongside increasing governmental and organizational support for TB control, further stimulate growth.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 2.52 Billion
Market Size 2030
USD 3.65 Billion
CAGR 2025-2030
6.37%
Fastest Growing Segment
Diagnostic Laboratory Methods
Largest Market
North America
Key Market Drivers
The advancements in diagnostic technologies significantly propel the global tuberculosis diagnostics market by enhancing the speed, accuracy, and accessibility of testing solutions. Innovations such as molecular diagnostics, artificial intelligence powered imaging, and next-generation sequencing are transforming the diagnostic landscape, enabling earlier detection and more effective disease management. These technological improvements are particularly crucial for identifying latent tuberculosis infection and for deployment in diverse healthcare settings, from central laboratories to point-of-care environments. For instance, according to a Pharmacy Times news report, in April 2025, the FDA approved the Auto-Pure 2400 liquid handling platform with the T-SPOT. TB test, which allows laboratories to process up to 24 samples in under 3.5 hours for faster and more accurate latent TB diagnosis.
Key Market Challenges
Ensuring affordable and accessible advanced diagnostic technologies in resource-limited regions presents a significant impediment to the expansion of the Global Tuberculosis Diagnostics Market. The high capital expenditure required for advanced molecular diagnostic platforms, coupled with the recurring costs of reagents and consumables, creates substantial financial barriers for public health systems in high-burden, low-income countries. This economic constraint often leads to the underutilization or non-adoption of advanced diagnostic tools despite their accuracy and speed.
Key Market Trends
The rise in automated diagnostic platforms significantly drives the global tuberculosis diagnostics market by enhancing testing throughput and operational efficiency. These systems streamline laboratory workflows, minimizing manual intervention and accelerating sample processing, thereby reducing turnaround times for results. By the end of 2023, the Stop TB Partnership reported that cumulative global procurement of GeneXpert machines, representing key automated molecular platforms, exceeded 16,000 units across 167 countries, demonstrating substantial integration into diagnostic infrastructure. This increased capacity is crucial for managing high sample volumes in high-burden settings.
Key Market Players
Abbott Laboratories Inc.
Becton, Dickinson, and Company
F. Hoffmann-La Roche Ltd.
Thermo Fisher Scientific Inc.
BioMerieux SA
Hain Lifescience GmbH
QIAGEN NV
Cepheid
Hologic, Inc.
Report Scope:
In this report, the Global Tuberculosis Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Tuberculosis Diagnostics Market, By Test Type:
Radiographic Method
Diagnostic Laboratory Methods
Nucleic Acid Testing
Phage Assay
Detection of Latent Infection
Cytokine Detection Assay
Detection of Drug Resistance (DST)
Others
Tuberculosis Diagnostics Market, By End-Use:
Diagnostic Laboratories
Hospitals & Clinics
Others
Tuberculosis Diagnostics Market, By Region:
North America
Europe
Asia-Pacific
South America
MEA
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Tuberculosis Diagnostics Market.
Available Customizations:
Global Tuberculosis Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Tuberculosis Diagnostics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Test Type (Radiographic Method, Diagnostic Laboratory Methods, Nucleic Acid Testing, Phage Assay, Detection of Latent Infection, Cytokine Detection Assay, Detection of Drug Resistance (DST), others)
5.2.2. By End-Use (Diagnostic Laboratories, Hospitals & Clinics, others)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Market Map
6. North America Tuberculosis Diagnostics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Test Type
6.2.2. By End-Use
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Tuberculosis Diagnostics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Test Type
6.3.1.2.2. By End-Use
6.3.2. Canada Tuberculosis Diagnostics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Test Type
6.3.2.2.2. By End-Use
6.3.3. Mexico Tuberculosis Diagnostics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Test Type
6.3.3.2.2. By End-Use
7. Europe Tuberculosis Diagnostics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Test Type
7.2.2. By End-Use
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Tuberculosis Diagnostics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Test Type
7.3.1.2.2. By End-Use
7.3.2. France Tuberculosis Diagnostics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Test Type
7.3.2.2.2. By End-Use
7.3.3. United Kingdom Tuberculosis Diagnostics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Test Type
7.3.3.2.2. By End-Use
7.3.4. Italy Tuberculosis Diagnostics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Test Type
7.3.4.2.2. By End-Use
7.3.5. Spain Tuberculosis Diagnostics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Test Type
7.3.5.2.2. By End-Use
8. Asia Pacific Tuberculosis Diagnostics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Test Type
8.2.2. By End-Use
8.2.3. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Tuberculosis Diagnostics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Test Type
8.3.1.2.2. By End-Use
8.3.2. India Tuberculosis Diagnostics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Test Type
8.3.2.2.2. By End-Use
8.3.3. Japan Tuberculosis Diagnostics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Test Type
8.3.3.2.2. By End-Use
8.3.4. South Korea Tuberculosis Diagnostics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Test Type
8.3.4.2.2. By End-Use
8.3.5. Australia Tuberculosis Diagnostics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Test Type
8.3.5.2.2. By End-Use
9. Middle East & Africa Tuberculosis Diagnostics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Test Type
9.2.2. By End-Use
9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Tuberculosis Diagnostics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Test Type
9.3.1.2.2. By End-Use
9.3.2. UAE Tuberculosis Diagnostics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Test Type
9.3.2.2.2. By End-Use
9.3.3. South Africa Tuberculosis Diagnostics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Test Type
9.3.3.2.2. By End-Use
10. South America Tuberculosis Diagnostics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Test Type
10.2.2. By End-Use
10.2.3. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Tuberculosis Diagnostics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Test Type
10.3.1.2.2. By End-Use
10.3.2. Colombia Tuberculosis Diagnostics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Test Type
10.3.2.2.2. By End-Use
10.3.3. Argentina Tuberculosis Diagnostics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Test Type
10.3.3.2.2. By End-Use
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Tuberculosis Diagnostics Market: SWOT Analysis
